APOE and Alzheimer disease: Furthermore, in response to stressors ranging from demyelination (Wang et al., 2022) to systemic immune challenge (Zhu et al., 2012) and AD-related pathology (Rodriguez et al., 2014; Liu et al., 2017), the APOE genotype strongly impacts indices of microglia activation.